Novel hemostatic gel and powder as rescue agents for arterial bleeding related to lumen-apposing metal stent placement
Open Access
- 14 January 2025
- journal article
- editorial
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (S 01) , E58-E59
Abstract
Intraprocedural bleeding following endoscopic ultrasound (EUS)-guided placement of lumen-apposing metal stents (LAMSs) is not an infrequent complication. Significant arterial bleeding may require interventions such as coil embolization or surgical intervention [1]. Identifying and accessing the bleeding site can be particularly challenging when it is obscured by the stent. Recent advances in topical hemostatic agents, such as gels and powders, offer the benefits of broad targeted therapy [2]. We report a unique case detailing the successful management of active arterial bleeding from the gastroepiploic artery after balloon dilation of a LAMS using topical hemostatic gel and powder ([Video 1]). A 39-year-old man with a history of necrotizing pancreatitis and walled-off pancreatic necrotic collections presented with abdominal pain and recurrent walled-off pancreatic necrosis. A computed tomography (CT) angiogram revealed no evidence of a pseudoaneurysm. Under EUS guidance, the stomach wall and the cyst were punctured using an electrocautery-equipped LAMS stent (AXIOS; Boston Scientific, Marlborough, Massachusetts, USA) ([Fig. 1]). A significant arterial bleed occurred from beneath the stent during dilation ([Fig. 2]). Hemostasis was achieved using topical hemostatic gel (PuraStat; 3-D Matrix Europe SAS, Caluire-et-Cuire, France) and powder (EndoClot Plus, Inc., Santa Clara, California, USA) ([Fig. 3], [Fig. 4], [Fig. 5]). The post-procedure CT angiogram showed no active bleeding, and the culprit was identified as the gastroepiploic artery. The patient remained stable and was discharged without requiring additional intervention. Topical hemostatic agents achieve hemostasis by forming mechanical barriers that enhance clot formation [3]. Hemostatic gel, in particular, maintains visibility and has a lower rebleeding rate [4]. While these agents are approved by the U.S. Food and Drug Administration for venous bleeding, their efficacy in managing arterial bleeding remains uncertain [5]. This case demonstrates the evolving role of topical hemostatic agents in managing complex bleeding situations where traditional methods are impractical. Further studies are warranted to refine management strategies and evaluate the long-term outcomes. Endoscopy_UCTN_Code_CPL_1AL_2AD Article published online: 23 January 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, GermanyKeywords
This publication has 5 references indexed in Scilit:
- Efficacy of a novel self-assembling peptide hemostatic gel as rescue therapy for refractory acute gastrointestinal bleedingEndoscopy, 2020
- Endoscopic Hemostasis for Non-Variceal Upper Gastrointestinal Bleeding: New FrontiersClinical Endoscopy, 2019
- Haemostasis and prevention of bleeding related to ER: The role of a novel self‐assembling peptideUnited European Gastroenterology Journal, 2019
- New and emerging endoscopic haemostasis techniquesFrontline Gastroenterology, 2015
- Endoscopic management of walled‐off pancreatic necrosisJournal of Hepato-Biliary-Pancreatic Sciences, 2014